Works matching IS 00278874 AND DT 2005 AND VI 97 AND IP 14
Results: 27
Erratum.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 14, p. 1096, doi. 10.1093/jnci/dji219
- Publication type:
- Article
Selective Reporting Biases in Cancer Prognostic Factor Studies.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 14, p. 1043, doi. 10.1093/jnci/dji184
- By:
- Publication type:
- Article
Re: Prognositc Significance of a Short Sequence Insertion of the MCL-1 Promoter in Chronic Lymphocytic Leukemia.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Erratum.
- Published in:
- 2005
- Publication type:
- Correction Notice
RESPONSE.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Re: Prognositc Significance of a Short Sequence Insertion of the MCL-1 Promoter in Chronic Lymphocytic Leukemia.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Re: Prognositc Significance of a Short Sequence Insertion of the MCL-1 Promoter in Chronic Lymphocytic Leukemia.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Urinary Melatonin Levels and Breast Cancer Risk.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 14, p. 1084, doi. 10.1093/jnci/dji190
- By:
- Publication type:
- Article
Re: Prognositc Significance of a Short Sequence Insertion of the MCL-1 Promoter in Chronic Lymphocytic Leukemia.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Re: Prognositc Significance of a Short Sequence Insertion of the MCL-1 Promoter in Chronic Lymphocytic Leukemia.
- Published in:
- 2005
- By:
- Publication type:
- Letter
The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 14, p. 1072, doi. 10.1093/jnci/dji187
- By:
- Publication type:
- Article
Risk of Contralateral Testicular Cancer: A Population-based Study of 29515 U.S. Men.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 14, p. 1056, doi. 10.1093/jnci/dji185
- By:
- Publication type:
- Article
Human Papillomavirus Type 16 Infections and 2-Year Absolute Risk of Cervical Precancer in Women With Equivocal or Mild Cytologic Abnormalities.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 14, p. 1066, doi. 10.1093/jnci/dji186
- By:
- Publication type:
- Article
Prevalence of an Expenditures for the Five Most Costly Medical Conditions.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 14, p. 1034, doi. 10.1093/jnci/dji208
- Publication type:
- Article
Awards, Appointments, Announcements.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 14, p. 1034, doi. 10.1093/jnci/dji230
- Publication type:
- Article
Risk Reduction Works for BRCA Mutation Carriers&With Heavy Costs.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 14, p. 1032, doi. 10.1093/jnci/dji228
- By:
- Publication type:
- Article
Bortezomib May Be More Effective, but More Toxic, for Multiple Myeloma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 14, p. 1031
- By:
- Publication type:
- Article
FDA, AstraZeneca Limit Distribution of Gefitinib.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 14, p. 1031
- By:
- Publication type:
- Article
Efficacy of Breast Cancer Screening in the Community According to Risk Level.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 14, p. 1035, doi. 10.1093/jnci/dji183
- By:
- Publication type:
- Article
NCI To Revamp Clinical Trials System in 2006.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 14, p. 1031
- By:
- Publication type:
- Article
Two HPV Vaccines Yielding Similar Success.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 14, p. 1030, doi. 10.1093/jnci/dji227
- By:
- Publication type:
- Article
Targeting Teens and Adolescents for HPV Vaccine Could Draw Fire.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 14, p. 1030, doi. 10.1093/jnci/dji226
- By:
- Publication type:
- Article
New Studies Look Beyond EGFR Mutations for Clues to Sensitivity to Erlotinib.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 14, p. 1028, doi. 10.1093/jnci/dji225
- By:
- Publication type:
- Article
New Checkpoint Blocker's Begin Human Trials.
- Published in:
- 2005
- By:
- Publication type:
- Editorial
Identification of Clinically Useful Cancer Prognostic Factors: What Are We Missing?.
- Published in:
- 2005
- By:
- Publication type:
- Editorial
Effectiveness: The Next Question for Breast Cancer Screening.
- Published in:
- 2005
- By:
- Publication type:
- Editorial